Nobelpharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsNobelpharma

Nobelpharma

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Hyftor	Sirolimus	2022-03-22	2029-2040	Kidney transplantation , Lymphangioleiomyomatosis , Perivascular epithelioid cell neoplasms , Graft rejection

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

therapeutic equivalency

,

acanthosis nigricans

,

tuberous sclerosis

,

,

,

neurofibromatosis 1

,

neurofibromatoses

,

,

,

urologic neoplasms

,

,

,

transitional cell carcinoma

,

myeloid leukemia acute

,

monocytic leukemia acute

,

eyelid neoplasms

,

precursor cell lymphoblastic leukemia-lymphoma

,

burkitt lymphoma

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

philadelphia chromosome

healthy volunteers/patients

,

,

bacterial pneumonia

,

duchenne muscular dystrophy

,

muscular dystrophies

,

,

communicable diseases

,

,

myeloid leukemia acute

,

deficiency diseases

,

paraproteinemias

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

breast neoplasms

,

immune system diseases

,

hematologic neoplasms

,

type 2 diabetes mellitus

,

,

metabolic diseases

,

,

glycogen storage disease

,

,

immunoglobulin g4-related disease

,

,

myeloid leukemia

,

,

falciparum malaria

,

,

,

,

,

polycystic kidney diseases

,

autosomal dominant polycystic kidney

,

,

,

renal insufficiency

,

hematologic diseases

,

blood protein disorders

,

neoplasms by histologic type

,

prostatic neoplasms

,

circulating neoplastic cells

,

x-linked bulbo-spinal atrophy

,

heart transplantation

,

non-small-cell lung carcinoma

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

esophageal neoplasms

,

,

neoplasm metastasis

,

aplastic anemia

,

multiple myeloma

,

hypercholesterolemia

,

meningococcal infections

,

plasma cell neoplasms

,

hemolytic anemia autoimmune

,

,

meningococcal meningitis

,

stomach neoplasms

,

,

kidney diseases

,

gaucher disease

,

,

chronic renal insufficiency

,

hyperphosphatemia

,

multiple sclerosis

,

,

homozygous familial hypercholesterolemia

,

hyperlipoproteinemia type ii

,

,

,

healthy volunteers/patients

,

,

glycogen storage disease type ii

,

atopic dermatitis

,

diabetes mellitus

,

insulin resistance

,

,

glycogen storage disease type iii

,

,

non-hodgkin lymphoma

,

,

postmenopausal osteoporosis

,

,

lymphoproliferative disorders

hemolytic-uremic syndrome

breast neoplasms

,

,

non-small-cell lung carcinoma

,

,

colorectal neoplasms

essential thrombocythemia

,

polycythemia vera

,

primary myelofibrosis

,

,

,

myelodysplastic syndromes

,

myeloid leukemia acute

,

gata2 deficiency

,

myeloid leukemia

,

,

,

,

multiple myeloma

,

plasma cell neoplasms

,

promyelocytic leukemia acute

breast neoplasms

,

triple negative breast neoplasms

,

,

cytomegalovirus retinitis

,

tympanic membrane perforation

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use